MedPath

University of Milan

University of Milan logo
🇮🇹Italy
Ownership
Private
Established
1924-01-01
Employees
1K
Market Cap
-
Website
http://www.unimi.it

Clinical Trials

168

Active:2
Completed:98

Trial Phases

4 Phases

Phase 2:11
Phase 3:10
Phase 4:23
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (106 trials with phase data)• Click on a phase to view related trials

Not Applicable
62 (58.5%)
Phase 4
23 (21.7%)
Phase 2
11 (10.4%)
Phase 3
10 (9.4%)

Nutrient And Non-Nutrient Intake, Relative Biomarkers and Their Health Effects In Apparently Healthy Participants

Active, not recruiting
Conditions
Participants With/Without Risk Factors for Metabolic Diseases
First Posted Date
2025-08-08
Last Posted Date
2025-08-08
Lead Sponsor
University of Milan
Target Recruit Count
200
Registration Number
NCT07110805
Locations
🇮🇹

Division of Human Nutrition Department of Food, Environmental and Nutritional Sciences - DeFENS Università degli Studi di Milano, Milan, Italy

Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes

Not Applicable
Completed
Conditions
Glucose Monitoring, Continuous
First Posted Date
2025-07-29
Last Posted Date
2025-07-29
Lead Sponsor
University of Milan
Target Recruit Count
260
Registration Number
NCT07089979
Locations
🇮🇹

ASST Sacco Fatebenefratelli, Milano, Milan, Italy

Sleep Hygiene Strategies Among Track and Field Athletes

Not Applicable
Completed
Conditions
Sleep
Athlete
First Posted Date
2025-07-24
Last Posted Date
2025-07-24
Lead Sponsor
University of Milan
Target Recruit Count
66
Registration Number
NCT07083544
Locations
🇮🇹

Department of Biomedical Sciences for Health | Università degli Studi di Milano, Milan, Italy

Efficacy of Corrective Rubber Insoles in Healthcare Professionals With Foot Overpronation

Not Applicable
Recruiting
Conditions
Hyperpronation
Overpronation
Pes Planus
First Posted Date
2025-06-03
Last Posted Date
2025-06-03
Lead Sponsor
University of Milan
Target Recruit Count
52
Registration Number
NCT07000838
Locations
🇮🇹

ASST Gaetano Pini-CTO, Milan, Italy

Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue

Recruiting
Conditions
Arthroscopic Rotator Cuff Repair
Augmentation
Microfragmented Adipose Tissue
First Posted Date
2025-05-07
Last Posted Date
2025-05-07
Lead Sponsor
University of Milan
Target Recruit Count
52
Registration Number
NCT06960343
Locations
🇮🇹

ASST Gaetano Pini-CTO, Milan, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 34
  • Next

News

SonoClear System Receives FDA Breakthrough Device Designation for Enhanced Brain Tumor Surgery Imaging

The FDA has granted breakthrough device designation to the SonoClear System, an acoustic coupling fluid designed to improve ultrasound clarity during brain tumor resection surgery.

IFB-088 Shows Promise in Phase 2 Trial for Bulbar-Onset ALS, Demonstrating Slower Disease Progression

Phase 2 clinical trial demonstrates IFB-088 (icerguastat) meets primary safety endpoint and shows significant reduction in disease progression for bulbar-onset ALS patients.

FDA Grants IDE Approval for Newronika's Novel Adaptive Deep Brain Stimulation System for Parkinson's Disease

• Newronika has received FDA Investigational Device Exemption (IDE) approval to commence a pivotal trial evaluating their adaptive deep brain stimulation system for movement disorders, particularly Parkinson's disease. • The company's innovative AlphaDBS system utilizes real-time brain signal feedback to deliver personalized stimulation therapy, potentially offering improved outcomes over conventional DBS treatments. • The upcoming multinational pivotal trial will compare the adaptive system's performance against traditional DBS in advanced Parkinson's disease patients, marking a crucial step toward U.S. regulatory approval.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.